ENDRA Life Sciences Inc.
NDRA· Nasdaq
NDRAENDRA Life Sciences Inc.
Filed Aug 13, 2018 · 10-Q · 44 days after period end · 0001654954-18-008949
| Metric | Q2 2018 | Q2 2017 | Q2 2016 |
|---|---|---|---|
| Revenue | $0.00 | $57.77K | — |
| Net Income | -$1.85M | -$1.43M | -$729.11K |
| EPS Diluted | -$0.47 | -$0.59 | -$1.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ENDRA Life Sciences Inc. · CIK 1681682 · Engraved from SEC EDGAR
ended Jun 30, 2018 · filed Aug 13, 2018 · 44 d after period end
